Cargando…
Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
Secondary amyloid A (AA) amyloidosis is a late and serious complication of poorly controlled, chronic inflammatory diseases. Rheumatoid arthritis (RA) patients with poorly controlled, longstanding disease and those with extra-articular manifestations are under risk for the development of AA amyloido...
Autores principales: | Kilic, Levent, Erden, Abdulsamet, Sener, Yusuf Ziya, Armagan, Berkan, Sari, Alper, Kalyoncu, Umut, Karadag, Omer, Akdogan, Ali, Dogan, Ismail, Apras Bilgen, Sule, Kiraz, Sedat, Ertenli, Ihsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316109/ https://www.ncbi.nlm.nih.gov/pubmed/30400666 http://dx.doi.org/10.3390/biom8040136 |
Ejemplares similares
-
The impact of antiphospholipid antibodies in Takayasu arteritis
por: FIRAT ŞENTÜRK, Esra, et al.
Publicado: (2022) -
Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
por: Armagan, Berkan, et al.
Publicado: (2018) -
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
por: KILIÇ, Levent, et al.
Publicado: (2020) -
Increased psoriasis frequency in patients with familial Mediterranean fever
por: Erden, Abdulsamet, et al.
Publicado: (2018) -
How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
por: Sarı, Alper, et al.
Publicado: (2020)